专题:Liver Disease Diagnosis and Treatment

This cluster of papers focuses on the epidemiology, diagnosis, management, and pathogenesis of Nonalcoholic Fatty Liver Disease (NAFLD). It covers topics such as liver fibrosis, insulin resistance, hepatic steatosis, metabolic syndrome, nonalcoholic steatohepatitis (NASH), and non-invasive assessment methods. The papers also discuss the association of NAFLD with hepatocellular carcinoma and its impact on public health.
最新文献
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

article Full Text OpenAlex

Solanum nigrum L. berries extract ameliorated the alcoholic liver injury by regulating gut microbiota, lipid metabolism, inflammation, and oxidative stress

article Full Text OpenAlex

Roles of Traditional and Next-Generation Probiotics on Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH): A Systematic Review and Network Meta-Analysis

review Full Text OpenAlex

The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

article Full Text OpenAlex

Multiclass liver disease prediction with adaptive data preprocessing and ensemble modeling

article Full Text OpenAlex

NUP85 alleviates lipid metabolism and inflammation by regulating PI3K/AKT signaling pathway in nonalcoholic fatty liver disease

article Full Text OpenAlex

Platelet, Antiplatelet Therapy and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

review Full Text OpenAlex

Incretin-based investigational therapies for the treatment of MASLD/MASH

article Full Text OpenAlex

Assessing the predictive value of insulin resistance indices for metabolic syndrome risk in type 2 diabetes mellitus patients

article Full Text OpenAlex

PNPLA3 rs738409, age, diabetes, sex, and advanced fibrosis jointly contribute to the risk of major adverse liver outcomes in metabolic dysfunction-associated steatotic liver disease

article Full Text OpenAlex

近5年高被引文献
Hepatocellular carcinoma

review Full Text OpenAlex 5784 FWCI756.60826647

Non-alcoholic fatty liver disease

review Full Text OpenAlex 2416 FWCI345.54240432

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

article Full Text OpenAlex 2323 FWCI820.14536295

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

review Full Text OpenAlex 2282 FWCI810.96594864

Baveno VII – Renewing consensus in portal hypertension

review Full Text OpenAlex 2244 FWCI257.87934484

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

review Full Text OpenAlex 2166 FWCI766.12804029

Hepatocellular carcinoma

review Full Text OpenAlex 1910 FWCI364.82617662

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

review Full Text OpenAlex 1826 FWCI412.26249453

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

article Full Text OpenAlex 1762 FWCI621.37573775

Global burden of primary liver cancer in 2020 and predictions to 2040

article Full Text OpenAlex 1648 FWCI370.96891859